What Testosterone Does in the Body, and Why the Numbers Are Slippery

Testosterone is a signaling molecule, not a scoreboard. It circulates at levels that swing across the day, drift with age, and get read by laboratory assays that do not fully agree with one another. That is why a single number on a printout, however precise it looks, is a weak basis for a diagnosis. A confirmed diagnosis of hypogonadism, the clinical term for a body that does not make enough testosterone, requires consistent symptoms together with more than one low measurement drawn under the right conditions, interpreted by a clinician who knows the person, not the lab slip alone.

What testosterone actually does

Testosterone is an androgen, a steroid hormone built from cholesterol and released mainly by the testes in men, with smaller contributions from the ovaries and adrenal glands in women. Its production sits under a feedback loop: the hypothalamus and pituitary in the brain send signals (GnRH, then LH and FSH) that tell the gonads how much to make, and rising testosterone quiets those signals back down. When that loop works, the system self-corrects.

In development, testosterone drives male sexual differentiation and, at puberty, the changes people associate with it: deeper voice, body hair, growth of the genitals. In adults it contributes to sperm production, bone density, muscle mass, and red blood cell production, and it plays a role in libido and mood. Some of its effects happen after the body converts it into other molecules, including estradiol, which is why testosterone matters for bone even in men. The hormone does a lot, which is exactly why the marketing around it tends to promise even more.

Why the numbers move

Here is the part the glossy panels rarely emphasize. Testosterone is not a fixed personal constant. It follows a daily rhythm, generally highest in the morning and lower later in the day, especially in younger men. Eating can push a reading down, since food and glucose intake suppress the measurement. Acute illness, poor sleep, heavy recent exertion, and some medications all move the number. Two blood draws from the same healthy person on two mornings can differ meaningfully, and neither is "wrong."

Age adds a slow drift. Average testosterone declines gradually across adult life, but the population range is wide, and a level that is low for a 30-year-old may be unremarkable for an older man. There is no bright line where a normal number becomes a disease. The decline being gradual and variable is precisely what makes age-related interpretation hard.

Then there is the assay itself. Most of the testosterone in blood is bound to proteins, chiefly sex hormone-binding globulin (SHBG) and albumin, and only a small free fraction is unbound. Conditions that change SHBG, such as obesity, thyroid disease, or aging, shift the total number without necessarily changing the biologically active fraction. Because only a few percent of testosterone is free, small measurement errors get amplified when free testosterone is calculated. Laboratories use different methods and report different reference ranges, and even total testosterone assays have shown enough inter-laboratory spread that the CDC runs a standardization program to bring certified assays into closer agreement. A result near the edge of "normal" can land on either side depending on which lab ran it and when the blood was drawn.

Symptoms are not the same as a diagnosis

Fatigue, low libido, low mood, and reduced strength are real and worth taking seriously. They are also nonspecific, meaning they overlap with sleep problems, depression, thyroid disease, anemia, medication effects, and ordinary life stress. Low testosterone can produce these symptoms; so can a dozen other things. This is the trap in "Is it Low T?" style self-scoring quizzes: they convert vague, common experiences into a suggestion of a hormonal cause and, often, a nudge toward a product. A checklist is not a diagnosis, and no online quiz can confirm one.

Major clinical guidance converges on a more careful path. A diagnosis of hypogonadism is reserved for people who have both symptoms and signs consistent with testosterone deficiency and unequivocally low testosterone, confirmed by repeating a morning, fasting measurement on a separate day. If the level is low, the workup usually continues to ask why, since the cause (a problem in the testes versus in the pituitary or hypothalamus) changes the picture entirely. That sequence, symptoms plus repeated confirmation plus a search for cause, is the opposite of acting on one screening value.

What the evidence base says, and what it does not

The research here has matured, and it helps to be precise about what it shows. The largest randomized trial to date, TRAVERSE, enrolled more than 5,000 middle-aged and older men with hypogonadism and existing cardiovascular disease or risk factors, published in the New England Journal of Medicine in 2023. It was designed to test cardiovascular safety and found no significant difference in major adverse cardiac events between testosterone and placebo over the study period. It also reported more cases of certain problems in the testosterone group, including some arrhythmias, venous blood clots, and fractures.

Regulators responded to that evidence. In 2025 the FDA made class-wide labeling changes across testosterone products: it removed the older boxed warning about cardiovascular risk in light of the trial data, while adding warnings about increased blood pressure and keeping a "limitation of use" note stating these products are not established for the low testosterone of normal aging alone. Read carefully, that is a narrowing of claims, not an endorsement of broad use. The evidence supports safety questions being addressed in men with confirmed hypogonadism; it does not turn testosterone into a general wellness intervention, and it does not answer whether treating an otherwise healthy older man with a borderline number helps him.

None of this is a recommendation for or against therapy. Whether testing is appropriate, how to interpret a result, and whether any treatment makes sense are decisions for a person and a qualified clinician who can weigh the full history. The honest summary is that testosterone is a powerful hormone measured by imperfect tools in a body that keeps changing the reading, so a number is a starting question, not an answer.

This article is educational and not medical advice. If you have symptoms or questions about your own hormones, talk to your own clinician.